Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Clinical Efficacy of Sodium Aescinate: A Double-Blind, Randomized Controlled Trial for the Treatment of Low Back Pain (LBP) in Adults

NCT07339631 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT07339631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07339631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Clinical Efficacy of Sodium Aescinate: A Double-Blind, Randomized Controlled Trial for the Treatment of Low Back Pain (LBP) in Adults
Lead sponsor
Xijing Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
March 1, 2026
Completion date
September 1, 2029
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clbp - chronic low back pain, low back pain, non-specific chronic low back pain, paraspinal muscle